Impact of Rechallenge with Imatinib in Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib
Purpose. This retrospective, nonrandomized study investigated the effect of imatinib rechallenge plus best supportive care (BSC) on overall survival after imatinib and sunitinib treatment for patients with locally advanced or metastatic gastrointestinal stromal tumor (GIST). Methods. Twenty-six pati...
Saved in:
| Main Authors: | Akira Sawaki, Tatsuo Kanda, Yoshito Komatsu, Toshirou Nishida |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Gastroenterology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2014/342986 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of ubiquitination and deubiquitination to imatinib resistance in gastrointestinal stromal tumors
by: Huade Huo, et al.
Published: (2025-07-01) -
Rhabdomyosarcomatous Transformation of a Gastrointestinal Stromal Tumor following Treatment with Imatinib
by: Xiaoyin Jiang, et al.
Published: (2015-01-01) -
Tyrosine Kinase Inhibitors for Gastrointestinal Stromal Tumor After Imatinib Resistance
by: Xian-Hao Xiao, et al.
Published: (2025-07-01) -
Imatinib enchances the sensitivity of gastrointestinal stromal tumors to topoisomerase II inhibitors
by: S. V. Boichuk, et al.
Published: (2015-06-01) -
Gastrointestinal stromal tumors with an uncommon primary mutation responded well to imatinib
by: Gilani Shahid, et al.
Published: (2025-03-01)